Lower urinary tract symptoms (LUTS) often start about 8 years after multiple sclerosis (MS) diagnosis, with urgency being the most common issue.
In a study of 1,167 people with MS, researchers found that most experienced urinary symptoms like urgency around 8 years after their MS diagnosis. Urgency means feeling a strong need to go to the bathroom quickly, which was reported by 51% of participants. Other symptoms included trouble holding urine or feeling like you still need to go after using the bathroom. Age, disability level, and certain symptoms at diagnosis were linked to starting these urinary problems sooner. This means that the younger and less disabled someone is when diagnosed, the longer they might go without these issues.
This study is important for MS patients and their caregivers because it highlights when to expect urinary challenges. Knowing that urgency is common can help patients prepare and seek help early on. Caregivers can support their loved ones by understanding these symptoms and discussing them openly. Healthcare providers can use this information to monitor and manage urinary symptoms more effectively. This understanding can improve daily life by making it easier to handle bathroom needs without embarrassment or anxiety.
The study included a specific group of MS patients, which might not represent everyone with MS. It also focused on symptoms that were reported during routine check-ups, meaning some patients might not have shared their experiences. These limitations matter because they remind patients and caregivers to communicate openly with healthcare providers about urinary issues, even if they are uncomfortable.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/1/2026
Discover how the CEAM tool aids in understanding DNA changes in brain cells, offering hope for bette
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read More3/1/2026
Learn about the risks of enterovirus encephalitis for MS patients on ocrelizumab and how early recog
Read More3/1/2026
Learn how TREM2 helps brain immune cells switch to a repair mode, reduce inflammation, and may suppo
Read More3/1/2026
Discover how new research could help women with MS produce more IL-10, an important substance for co
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like World journal of urology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.